Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 16/20 | 0.73 |
| ▸ | ACHE | P22303 | 14/20 | 0.73 |
| ▸ | PPARA | Q07869 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 1/20 | 0.67 |
| ▸ | MAOB | P27338 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14634860 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL14634858 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL7056399 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL2996225 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL7056394 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL2996226 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL7058896 | 1.00 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL3005010 | 0.99 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL3005012 | 0.99 | BCHE (0.73) | BCHEACHEPPARAMAOAMAOB | |
| SCHEMBL17457082 | 0.96 | BCHE (0.69) | BCHEACHEPPARAMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| WO-2024233598-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2024-11-14 | — | — | WO | disclosed |
| EP-4429763-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | Yewsavin, Inc. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2003-06-05 | — | — | US | disclosed |
| US-6495221-B1 | EXTREMELY THIN AND TRANSPARENT FILM IN NANOMETER ORDER; HYDROCHALCONE DERIVATIVE SUBSTITUTED WITH A ISOCYANATOSILYL GROUP | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2002-12-17 | — | — | US | disclosed |
| EP-0962460-A1 | CHEMISORPTIVE SUBSTANCE, ALIGNED LIQUID-CRYSTAL FILM AND LIQUID-CRYSTAL DISPLAY ELEMENT BOTH MADE BY USING THE SAME, AND PROCESSES FOR PRODUCING THESE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104145-A1 | Chemical adsorbent and liquid crystal alignment layer utilizing the same and liquid crystal display device utilizing the same and methods of manufacturing them | UACA, CRYAA, CUTA | BCHE 3695/4885ACHE 2415/4885PPARA 2975/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | BCHE 588/4885ACHE 806/4885PPARA 4345/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | BCHE 465/4885ACHE 656/4885PPARA 4095/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | BCHE 465/4885ACHE 656/4885PPARA 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.